Bethlem Myopathy 1b C5935580
A mild inherited muscle disease involving collagen VI gene mutations. It causes mild to moderate muscle weakness that slowly progresses over time but often allows for a near-normal lifestyle.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Joint pain or stiffness
(musculoskeletal)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Proximal muscle weakness
(musculoskeletal)Mild axial hypotonia
(musculoskeletal)Joint hypermobility
(musculoskeletal)Feeding difficulties in infancy
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Aquatic therapy program
Water-based exercises that reduce joint stress while improving strength, flexibility, and cardiovascular fitness.
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Cardiac function evaluation
Regular cardiac assessments including echocardiography to screen for cardiomyopathy associated with collagen VI disorders.
Additional treatment options
Pain management therapy
Pharmacological and non-pharmacological approaches to manage chronic musculoskeletal pain associated with contractures.
medicationEnergy conservation techniques
Teaching patients strategies to conserve energy during daily activities and prevent fatigue.
lifestyleSpinal bracing or fusion
Orthopedic intervention for scoliosis or spinal deformity that may develop as the condition progresses.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Bethlem Myopathy 1b C5935580?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bönnemann CG, Wang CH, Quijije-Roy A, et al. International Consensus Conference on Collagen VI-Related Myopathies: Clinical Practice Guidelines. Neurology. 2022.
Böhm J, Peiris LN, Foley AR, et al. Collagen VIopathies: Clinical and Molecular Advances in Bethlem Myopathy and Ullrich Congenital Muscular Dystrophy. Neuromuscular Disorders. 2021.
Zulian F, Merlini L, Pini A, et al. Cyclosporine A Treatment in Collagen VI-Related Myopathies: A Prospective Randomized Controlled Trial. Journal of Clinical Investigation. 2020.
Camacho-Orduza A, Allamand V, Dulor K, et al. Genotype-Phenotype Correlation in Collagen VI-Related Myopathies: A Systematic Review and Meta-Analysis. Orphanet Journal of Rare Diseases. 2023.
Medication Comparisons
Compare medications used to treat Bethlem Myopathy 1b C5935580. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy